Stirling Products Limited
ASX:STI ISIN:AU000000STI8
Stirling Products recently acquired a Canadian company Progressive BioActives Incorporated (PBI) under its North American subsidiary, Stirling Products NA Inc. PBI is part of the Bioscience cluster established on located Prince Edward Island, Canada. PBI's lead product ProVale, is the latest high purity beta glucan extract that has been designed as an alternative tool for sustainable livestock management in face of increasing viral disease challenges where antibiotics have no or limited application. ProVale is available for targeted applications in swine, poultry and farmed aquaculture with a future focus on further developing applications for companion animals (e.g. horses, dogs, cats and reptiles).
News
Stirling Products Limited (ASX:STI), an animal healthcare development and commercialization company, today announced that it is launching its presence into the companion animal healthcare market at the BIO2008 Annual Convention in San Diego, June 17-20, 2008.
Stirling Products (ASX: STI) advises that its wholly-owned North American subsidiary, Stirling Products North America Inc (STI-NA), has successfully completed product validation trials in shrimp with a leading global animal pharma company for applications for its proprietary immunobiotic ProVale(TM).
Stirling Products (ASX:STI) advises shareholders that it has signed a term sheet with Aquience, a Canadian company, for the exclusive rights to its companion animal product PetQuench(tm), which is already being sold and distributed in North America.
Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary Stirling Products North America Inc. (STI-NA), has signed a Collaboration and Supply Agreement for its lead product ProVale(tm), a highly purified beta glucan.
Stirling Products (ASX: STI) advises that its South African partner, Afgri Limited, has submitted the next stage in the regulatory process towards Act 36 approval.
Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary, Stirling Products North America Inc (STI-NA), has now signed a lease agreement to become the cornerstone tenant in Prince Edward Island's newest commercial BioScience Park facility. STI-NA has signed the lease agreement within the new state of the art two storey 50,000 square foot bio facility.
Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary, Stirling Products North America Inc. (SPNA), has offered terms and conditions to Distribution Claude Levesque Inc. (DCL) to sell and distribute Stirling's beta glucan product ProVale. Under the terms of the Memorandum of Understanding, both parties will have three months to finalize a formal agreement.
Stirling Products Limited (ASX: STI) advises shareholders that it has signed a Term Sheet and Letter of Understanding with the company Equine Healthcare Limited, based in the United Kingdom, for the first option to license, manufacture and distribute its patented 'early detection device' for respiratory disorders.
Stirling Products North America Inc (trading as Progressive BioActives Inc) and PEI Pork Plus Inc have signed an MOU which provides Stirling with the opportunity to become the exclusive sales and distribution partner for PEI Pork's Omega-3 Meat Enhancement Technology. The MOU covers all livestock applications including swine, poultry, lamb and cattle markets in Australia, New Zealand and various Asian Pacific regions.
Stirling Products Limited (ASX: STI) advises shareholders that its North American subsidiary (Stirling Products North America Inc. trading as Progressive BioActives Inc.), has signed a Term sheet with US-based aquaculture company Aqua Bounty Technologies (London stock exchange symbol ABTX) to begin trials of ProVale(tm) in the Chilean salmon market.
13,239 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 27) (Last 30 Days: 132) (Since Published: 13239)